Desvenlafaxine
Desvenlafaxine is a pharmaceutical drug with 20 clinical trials. Currently 3 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
12 of 14 finished
14.3%
2 ended early
3
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Desvenlafaxine for Preventive Treatment of Frequent Migraines
Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Clinical Trials (20)
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Desvenlafaxine for Preventive Treatment of Frequent Migraines
Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression
Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment
Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities
Desvenlafaxine in Opioid-Dependent Patients
Switching From SSRI to Desvenlafaxine on Cognitive Functioning
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
Neurocognition and Work Productivity in Major Depressive Disorder (MDD)
Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
Desvenlafaxine Monotherapy in Dysthymia
Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet
Effect of Antidepressants on White Matter Structure
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20